Amgen (AMGN) EBT Margin (2009 - 2026)

Amgen (AMGN) has reported EBT Margin for 18 consecutive years, with 24.18% the latest figure, recorded in Q1 2026.

• In Q1 2026, EBT Margin fell 3.0% year-over-year to 24.18%; the TTM figure through Mar 2026 stood at 24.41% (up 493.0% YoY), while the FY2025 annual figure was 24.42%, up 1063.0% from the prior year.
• EBT Margin came in at 24.18% for Q1 2026 at Amgen, up from 15.35% in the prior quarter.
• The five-year high for EBT Margin was 380.83% in Q4 2022, with the low at 0.91% in Q1 2024.
• Average EBT Margin over 5 years is 44.73%, with a median of 24.18% recorded in 2026.
• Across the five-year window, EBT Margin jumped 34970 bps in 2022 and slumped 37043 bps in 2023, its largest moves.
• Year by year, EBT Margin stood at 380.83% in 2022, then sank by 97 bps to 10.4% in 2023, then decreased by 17 bps to 8.61% in 2024, then soared by 78 bps to 15.35% in 2025, then jumped by 58 bps to 24.18% in 2026.
• According to Business Quant data, EBT Margin over the past three periods registered 24.18%, 15.35%, and 41.03% for Q1 2026, Q4 2025, and Q3 2025 respectively.